PRLD
Prelude TherapeuticsANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
PRLD vs peer average
94/100
PRLD vs. peer average (A vs. D)
Grade spread
B 2 · C 2 · D 4 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ARVN is the first available peer comparator.
Larger, more clinically mature targeted-protein-degradation peer; useful for modality sentiment, but not a one-for-one valuation comp for PRLD.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
PRLD
Prelude Therapeutics
ARVN
Arvinas
Grade
A
C
Momentum
85
8
Value
41
57
Sentiment
75
90
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Mixed
Grade position vs ARVN
PRLD / ARVN
Grade Position
Above peers
PRLD vs. peer average (A vs. D)
94/100
Momentum
85
PRLDValue
41
ARVNSentiment
75
ARVNRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs PRLD
ARVN is the first peer returned for this comparison set.